212 related articles for article (PubMed ID: 16143484)
1. Tracking of the physical ageing of amorphous pharmaceutical polymeric excipients by positron annihilation spectroscopy.
Zelkó R; Orbán A; Süvegh K
J Pharm Biomed Anal; 2006 Feb; 40(2):249-54. PubMed ID: 16143484
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the stability of polymeric matrix tablets containing famotidine from the positron annihilation lifetime distributions of their physical mixtures.
Szente V; Süvegh K; Marek T; Zelkó R
J Pharm Biomed Anal; 2009 Apr; 49(3):711-4. PubMed ID: 19188038
[TBL] [Abstract][Full Text] [Related]
3. [Physical ageing of amorphous polymeric excipients III. The possible consequences of ageing].
Zelkó R; Kiss D
Acta Pharm Hung; 2006; 76(2):105-13. PubMed ID: 17094669
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the release characteristics of theophylline and the free volume of polyvinylpyrrolidone.
Zelkó R; Süvegh K
Eur J Pharm Sci; 2005 Mar; 24(4):351-4. PubMed ID: 15734301
[TBL] [Abstract][Full Text] [Related]
5. [Pphysical ageing of amorphous polymeric excipients II. Tracking possibilities].
Zelkó R; Kiss D
Acta Pharm Hung; 2006; 76(1):55-63. PubMed ID: 17094676
[TBL] [Abstract][Full Text] [Related]
6. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
8. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
9. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the enthalpy recovery and free volume of polyvinylpyrrolidone during anomalous glassy to rubbery transition.
Zelkó R; Süvegh K
Eur J Pharm Sci; 2004 Mar; 21(4):519-23. PubMed ID: 14998583
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the drug release stability of different polymeric matrix tablets containing metronidazole.
Szente V; Baska F; Zelkó R; Süvegh K
J Pharm Biomed Anal; 2011 Mar; 54(4):730-4. PubMed ID: 21129883
[TBL] [Abstract][Full Text] [Related]
12. [The effect of physical aging on the structural behavior of amorphous poly(vinylpyrrolidone) polymers].
Zelkó R; Süvegh K
Acta Pharm Hung; 2003; 73(1):46-50. PubMed ID: 12891899
[TBL] [Abstract][Full Text] [Related]
13. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
Jannin V; Pochard E; Chambin O
Int J Pharm; 2006 Feb; 309(1-2):6-15. PubMed ID: 16376034
[TBL] [Abstract][Full Text] [Related]
14. Depth profile of free volume in a mixture and copolymers of poly(N-vinyl-pyrrolidone) and poly(ethylene glycol) studied by positron annihilation spectroscopy.
Li Y; Zhang R; Chen H; Zhang J; Suzuki R; Ohdaira T; Feldstein MM; Jean YC
Biomacromolecules; 2003; 4(6):1856-64. PubMed ID: 14606919
[TBL] [Abstract][Full Text] [Related]
15. Controlled release from bioerodible polymers: effect of drug type and polymer composition.
Frank A; Rath SK; Venkatraman SS
J Control Release; 2005 Feb; 102(2):333-44. PubMed ID: 15653155
[TBL] [Abstract][Full Text] [Related]
16. Diclofenac release from eudragit-containing matrices and effects of thermal treatment.
Billa N; Yuen KH; Peh KK
Drug Dev Ind Pharm; 1998 Jan; 24(1):45-50. PubMed ID: 15605596
[TBL] [Abstract][Full Text] [Related]
17. Effect of storage on microstructural changes of Carbopol polymers tracked by the combination of positron annihilation lifetime spectroscopy and FT-IR spectroscopy.
Szabó B; Süvegh K; Zelkó R
Int J Pharm; 2011 Sep; 416(1):160-3. PubMed ID: 21726620
[TBL] [Abstract][Full Text] [Related]
18. [Physical ageing of amorphous polymeric excipients I. physicochemical principles].
Zelkó R; Kiss D
Acta Pharm Hung; 2005; 75(4):213-22. PubMed ID: 16711399
[TBL] [Abstract][Full Text] [Related]
19. [Positron annihilation lifetime spectrometry (PALS) and its pharmaceutical applications].
Sebe I; Szabó B; Zelkó R
Acta Pharm Hung; 2012; 82(1):23-32. PubMed ID: 22570984
[TBL] [Abstract][Full Text] [Related]
20. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
